news

Drone temperature-controlled medicine delivery programme test completed

78
SHARES

The successful pilot programme could represent an important step forward in biopharmaceutical supply chain innovation.

Direct Relief (a consortium led by humanitarian aid organisations) has announced the successful completion of a programme testing the potential to deliver temperature-controlled medicines and vaccines by using unmanned aerial vehicles (UAVs).

 

ACCESS your FREE COPY

 


This report addresses the key factors shaping pharmaceutical formulation, including regulation, QC and analysis.

Access the full report now to discover the techniques, tools and innovations that are transforming pharmaceutical formulation, and learn how to position your organisation for long-term success.

What you’ll discover:

  • Key trends shaping the pharmaceutical formulation sector
  • Innovations leading progress in pharmaceutical formulation and how senior professionals can harness their benefits
  • Considerations and best practices when utilising QbD during formulation of oral solid dosage forms
  • And more!

Don’t miss your chance to access this exclusive report ! Access now – it’s free

It is the fourth in a series of proof-of-concept missions the group has undertaken to demonstrate the potential of using UAVs to safely deliver temperature-dependent medicines and vaccines to hard-to-reach locations. 

The successful pilot programme and the potential of UAV technology could represent an important step forward in biopharmaceutical supply chain innovation and for humanitarian efforts around the world. 

“Experience and research consistently show that those most at risk of health crisis in disasters live in communities which are likely to be cut off from essential health care due to disruption of transportation and communications,” said Andrew Schroeder, who leads analytics programmes, data visualisation, and geospatial analytics for Direct Relief. “Drone delivery is one of the most promising answers to this problem. More remains to be done to operationalise medical cargo drones in emergencies. But successful tests like this one demonstrate that remarkable new humanitarian capabilities are emerging quickly.”

While the technology is promising, the potential viability of the technology for real-world application will depend on several factors, including tackling diverse and evolving regulatory challenges around the world.

The pilot test was conducted fully autonomously with cold-chain delivery technology allowing for precise temperature control of medicines and vaccines at temperatures as low as minus 70°C, the temperature required for storing and transporting some life-saving medicines and vaccines.

It utilised live, continuous temperature tracking through the duration of the flight with cloud-based, real-time data analysis and collection, designed to ensure safe and effective delivery.

In the test, a UAV flew over open water between the islands of the Bahamas, beyond the operator’s line of sight. The collaborators will now advance the pilot programme so the technology can be tested in Africa and Latin America. 

Share via
Share via